- Home
- RNXT vs ICMB Comparison
RNXT vs ICMB Comparison
Compare RNXT & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- ICMB
- Stock Information
- Founded
- RNXT 2012
- ICMB 2012
- Country
- RNXT United States
- ICMB United States
- Employees
- RNXT N/A
- ICMB N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- RNXT Health Care
- ICMB Finance
- Exchange
- RNXT Nasdaq
- ICMB Nasdaq
- Market Cap
- RNXT 35.2M
- ICMB 40.8M
- IPO Year
- RNXT 2021
- ICMB N/A
- Fundamental
- Price
- RNXT $0.78
- ICMB $2.79
- Analyst Decision
- RNXT Strong Buy
- ICMB
- Analyst Count
- RNXT 2
- ICMB 0
- Target Price
- RNXT $7.50
- ICMB N/A
- AVG Volume (30 Days)
- RNXT 371.1K
- ICMB 23.5K
- Earning Date
- RNXT 11-13-2025
- ICMB 11-12-2025
- Dividend Yield
- RNXT N/A
- ICMB 17.86%
- EPS Growth
- RNXT N/A
- ICMB 31.51
- EPS
- RNXT N/A
- ICMB 0.38
- Revenue
- RNXT $928,000.00
- ICMB $17,931,778.00
- Revenue This Year
- RNXT $2,895.35
- ICMB N/A
- Revenue Next Year
- RNXT $313.04
- ICMB N/A
- P/E Ratio
- RNXT N/A
- ICMB $7.30
- Revenue Growth
- RNXT N/A
- ICMB N/A
- 52 Week Low
- RNXT $0.70
- ICMB $2.46
- 52 Week High
- RNXT $1.69
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- RNXT 31.87
- ICMB 49.32
- Support Level
- RNXT $0.91
- ICMB $2.60
- Resistance Level
- RNXT $1.09
- ICMB $2.80
- Average True Range (ATR)
- RNXT 0.09
- ICMB 0.07
- MACD
- RNXT -0.02
- ICMB -0.00
- Stochastic Oscillator
- RNXT 14.69
- ICMB 63.35
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.